At a glance
After significant weight loss, I assess lost facial volume separately from loose skin and tissue descent. Fat grafting may help selected hollow areas; a facelift may address changes that adding volume alone will not resolve. Some patients benefit from a combined plan, while others should wait or choose no procedure. Taking a GLP-1 medication does not automatically create an indication for surgery. My assessment includes your weight trajectory, health, expectations, and medication plan.
You can value your progress and still have questions about your face
You do not have to be unhappy with losing weight to be surprised by a change in your face. You may feel better overall and still wonder why certain contours seem less familiar. I want to understand what you have noticed without assuming that a slimmer face is a problem that must be corrected.
Tell me what matters to you: a hollow area, the neck, the outline of the jaw, or an expression that looks more tired than you feel. These concerns can sound similar in conversation, but they may lead to different decisions after examination. I do not start by choosing a procedure from a photograph or a medication name.
The phrase “Ozempic face” is a popular label rather than a diagnosis. Cleveland Clinic explains that similar facial changes can occur after rapid weight loss through other means, including bariatric surgery or lifestyle changes. The label does not establish a problem unique to semaglutide. 1 I use a more specific description of the changes in front of me when discussing treatment.
Four possibilities I distinguish during assessment
Mainly lost volume
If a hollow area is the principal concern, I examine whether restoring volume would address it. Facial fat grafting uses your own fat, but suitability also depends on donor tissue and the proposed treatment area. I do not choose an amount simply to replace every visible sign of weight loss or recreate an earlier photograph exactly.
Mainly tissue descent or excess skin
If the main concern is loose tissue around the lower face or neck, adding volume may not answer the question. I may discuss a deep plane facelift when examination supports that approach. In my practice, deep neck work is performed together with a facelift, not as an isolated operation. That distinction matters when you are comparing the services available.
A combination of changes
A face can have both depleted areas and tissue descent. In that situation, I consider each part of the proposed plan separately: what repositioning would address, where fat might contribute, and what neither would correct. A combined plan needs a reason for each component. It is not automatically more appropriate just because it includes more procedures.
A reason to wait or reconsider surgery
I may recommend reassessment rather than scheduling an operation if your weight is still changing or if medical preparation is incomplete. I also want to know whether the change bothers you or whether someone else has made you feel that it should. An assessment can end with a decision not to operate; it is still a useful assessment.
Why I ask about your weight history
In my practice, I prefer to plan after your weight has stabilized. I do not assign the same waiting period to everyone. I ask how much your weight has changed, whether further loss is planned, how your treatment is progressing, and whether your prescribing clinician expects adjustments. These details help me understand the situation rather than treating one current measurement as the entire story.
Bring your history as clearly as you can. You do not need a perfect spreadsheet, but approximate dates and changes are more helpful than saying only that you have lost a lot. If the pace has recently changed or you are finding it difficult to eat adequately, tell the team. I want the surgical discussion to fit your broader medical care.
I do not recommend changing a successful medical treatment merely to simplify an aesthetic plan. The clinician managing your weight or diabetes remains part of the decision. If you receive different instructions from different professionals, bring that discrepancy to us so it can be clarified before surgery, rather than choosing between instructions yourself.
What fat grafting can offer, and what remains uncertain
Fat grafting is a procedure, not a guaranteed amount of permanent volume. A systematic review of facial fat grafting found incomplete retention and reported complications including asymmetry, contour irregularity, and prolonged swelling. Its pooled results are not a personal retention forecast. 2 I therefore discuss the intended correction and its limits rather than promising that all transferred fat will remain.
It is also important to understand that your own tissue is not automatically risk-free. A separate review of published complications documented serious outcomes, including vision loss and neurological injury. Because it collected complication reports, it cannot provide a reliable probability for every person considering the procedure. 3 My consultation includes risks relevant to the proposed areas, not only the benefits of using your own fat.
The dedicated fat-grafting guide explains the procedure in more detail. Here, the decision I want to clarify is whether volume loss is actually the concern we should address. More volume is not a substitute for deciding what has changed, and a plan should not depend on the assumption that every thinner face needs filling.
Do GLP-1 medications affect fat-graft survival?
This is a reasonable question, but it needs a careful answer. A 2026 scoping review examined possible interactions between incretin therapies and the biology involved in fat grafting. The authors reported that their search found no direct clinical or preclinical studies of graft outcomes during these therapies. Their suggestions were hypothesis-generating, not evidence-based treatment guidelines. 4
I would not turn that paper into a claim that your medication will destroy a graft, or that stopping it will improve retention. A biological explanation can suggest a research question without proving what happens in patients. The uncertainty should be acknowledged during planning rather than filled with a confident prediction.
That is also a different issue from medication management for anesthesia. One question concerns a theoretical effect on grafted tissue. The other concerns established precautions around the procedure itself. Combining the two into a universal instruction to stop treatment would lose an important distinction.
Medication and anesthesia: bring the details early
The American Society of Anesthesiologists explains that GLP-1 medications can delay stomach emptying, which matters during general anesthesia or deep sedation. Its patient guidance calls for discussion with the anesthesiologist, surgeon, and prescribing clinician; medication use, symptoms, and dose escalation can affect planning. 5
Tell my team the exact medication, dose, dosing schedule, recent changes, and any digestive symptoms. Include other medicines and supplements as well. I want that information available before the day of surgery, especially when you are arranging travel from another country.
Do not use this article to decide when to stop, restart, or change a medication. Ask for the instructions that apply to your planned procedure, including fasting, and confirm anything unclear. A general article cannot replace the coordinated plan for your health and anesthesia. My preoperative guide explains how we organize that preparation.
A useful consultation starts with specific questions
You can bring these questions to help organize the conversation:
- Which of my concerns comes from volume loss, and which comes from tissue position or skin?
- What would each proposed procedure address, and what would remain unchanged?
- Is my weight trajectory suitable for planning now?
- How will my prescribing clinician and anesthesiologist be involved?
- What are the main risks for the areas we are considering?
- What would make you recommend waiting or choosing no surgery?
I also want to know about previous fillers, facial surgery, or other treatments. If you have records, bring them. If you do not know what product was used, say so rather than guessing. The purpose is to make the assessment better informed, not to make you arrive with every answer already prepared.
Planning from outside Brazil
We can begin the discussion online, but the surgical plan must be confirmed in person. If you decide to travel for surgery, my usual planning is arrival two days before the operation and at least twelve days afterward; fourteen days is preferable. These are planning intervals, not automatic clearance to fly. Your recovery still needs individual assessment.
The patient journey brings together the consultation, preparation, hospital stay, and follow-up. I follow patients for one year, with online appointments available after returning home when an in-person visit is not possible. Arrange the practical details before booking so that the trip supports your care rather than compressing the time needed for it.
Frequently asked questions
Does everyone with “Ozempic face” need treatment?
No. I assess the specific concern and whether you want to address it. The popular label alone is not a diagnosis or a reason to have surgery. You can ask for an assessment without having decided to undergo a procedure.
Is fat grafting always part of a facelift after weight loss?
No. I consider whether there is a volume concern that fat grafting could reasonably address. The choice is based on examination and your goals, not on the name of the medication you take.
Can I have filler instead?
Fillers are a different option that can be discussed when appropriate, but I do not offer filler injections in my current practice. An explanation of an alternative should not be mistaken for an available service or a claim that it suits every area of concern.
Should I stop my medication to protect the graft?
Do not stop it on the basis of that assumption. The scoping review does not demonstrate that withholding treatment improves graft survival. 4 Medication instructions for surgery need coordination with your anesthesiologist and prescribing clinician.
Do I need to regain weight before a consultation?
No—not simply to prepare for this consultation. Do not change your weight-management plan without discussing it with your treating clinician. Tell me about your current medical plan and concerns. We can discuss assessment in the context of that plan rather than setting an aesthetic target without knowing your health history.
Can you guarantee one treatment will solve every change?
No. I explain the purpose and limitations of the proposed plan, including what may remain and whether further assessment or treatment could be needed. A clear plan is more useful than a promise to correct every visible effect of aging or weight loss.
Let us understand the change before choosing the procedure
Bring the concern that led you here, not a requirement to have a particular operation. I will explain what I see, how it relates to your goals, and whether a procedure makes sense now.
Bruna is your first contact through this English-language site. On the contact page, you can tell her where you live and ask about arranging an assessment with me. That conversation can help you understand the next step before committing to travel.
References
1. Cleveland Clinic. What is Ozempic face? 2025. Cleveland Clinic: facial changes after weight loss
2. Gornitsky J et al. A systematic review of the effectiveness and complications of fat grafting in the facial region. JPRAS Open. 2019;19:87–97. Gornitsky: facial fat grafting review
3. Brucato D et al. Complications Associated with Facial Autologous Fat Grafting for Aesthetic Purposes: A Systematic Review of the Literature. PRS Global Open. 2024;12(1):e5538. Brucato: fat grafting complications
4. Chalhoub X, Ng ZY. Do GLP-1 Receptor Agonists Sabotage Fat Grafts? A Scoping Review of GLP-1 Receptor Agonist Effects on Adipocyte Biology and Implications for Autologous Fat Transfer. Aesthetic Surgery Journal. 2026;sjag108. Chalhoub and Ng: GLP-1 and graft biology
5. American Society of Anesthesiologists. Drugs for Diabetes or Weight Loss: What to Know Before Surgery. Patient guidance reviewed October 22, 2025. ASA: GLP-1 medication and surgery